Swedish Cancer Institute — Seattle, Washington

Public research footprint of Swedish Cancer Institute, compiled from the ClinicalTrials.gov public registry.

726

Registered studies

286

Active

125

Recruiting now

319

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia Arising From Previous… · Stage IIIB Lung Cancer AJCC v8 · Recurrent Malignant Female Reproductive System Neoplasm · Lung Non-Small Cell Carcinoma

Recently updated registry entries

NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT04527549 — Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV… (Terminated)
NCT06096844 — Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Swedish Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.